VERTEX PHARMACEUTICALS INC / MA (VRTX)
Pharmaceutical Preparations · Healthcare · $115.2B
Intrinsic Value (Consensus)
$202.99
Current Price
$453.17
Margin of Safety
-55.2%
55.2% Above Intrinsic Value
Value: $203
Price: $453
Valuation Model Estimates
Current Price: $453.17
DCF (Discounted Cash Flow)
$197.72
Graham Number
$159.11
Earnings Power Value
$148.74
Relative Value (P/E)
$306.40
Dividend Discount Model
Not applicable
—
Consensus Value
$202.99
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
22/25
Strength
24/25
Valuation
7/25
Growth
10/25
Financial Health Signals
Strong profitability — ROE of 21% (above 20% is excellent)
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $15.32
- EPS (Forward)
- $16.09
- Book Value
- $73.44
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 21.2%
- Debt/Equity
- 1%
- Revenue Growth
- 8.9%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance